CSF1R+ macrophage and osteoclast depletion impairs neural crest proliferation and craniofacial morphogenesis

This study demonstrates that prenatal depletion of CSF1R+ macrophages and osteoclasts via PLX5622 treatment impairs neural crest proliferation and disrupts craniofacial morphogenesis, leading to significant skeletal defects and altered cytokine signaling.

The Gist

The Big Picture: The Construction Crew That Wasn't Invited

Imagine your baby's face is a massive construction site. To build a beautiful, functional house (a skull, jaw, and face), you need architects, bricklayers, and a very specific type of cleanup crew.

In this study, scientists discovered that macrophages (a type of immune cell) and osteoclasts (cells that eat away old bone) are not just the cleanup crew; they are actually essential foremen who tell the construction workers when to build and how much to build.

The researchers used a special "off-switch" drug called PLX5622 to temporarily remove these foremen from the construction site of developing mouse embryos. They wanted to see what happens to the face when these cells are missing.

The Experiment: Turning Off the Foremen

The scientists fed pregnant mice this drug starting very early in pregnancy. The drug worked like a targeted vacuum cleaner:

• It removed about 50% of the macrophages (the general cleanup crew).
• It removed 100% of the osteoclasts (the bone-eating crew).

They checked the embryos at different stages, from early development to just after birth, to see how the "house" was coming along.

The Results: A House Built Wrong

When the foremen were missing, the construction site went haywire. Here is what happened, explained through our construction analogy:

1. The "Bone-Eaters" Were Gone, So the Walls Got Too Thick
Normally, osteoclasts are like demolition experts. They chew away old or excess bone to make room for new growth and to shape the final structure. Without them, the bone didn't get shaped correctly.

• The Analogy: Imagine a sculptor trying to carve a statue but forgetting to use the chisel to remove the excess stone. The result is a blocky, misshapen lump instead of a smooth face.
• The Reality: The mice had thicker, denser bone in their jaws and upper lips (premaxilla) because nothing was there to trim it down.

2. The "Cleanup Crew" Was Missing, So Trash Piled Up
Macrophages are the janitors of the body. Their job is to eat up dead cells and debris so new cells can grow in a clean environment.

• The Analogy: If you don't take out the trash, the room gets so cluttered that the new furniture (new cells) can't fit in.
• The Reality: In areas like the ears and eyes, dead cells piled up because no one was there to clean them. This caused developmental glitches.

3. The "Architects" (Neural Crest Cells) Lost Motivation
The most surprising discovery was about the Neural Crest Cells. Think of these as the master architects and bricklayers who actually build the face. They need signals from the foremen (macrophages) to know how fast to multiply and where to go.

• The Analogy: The foremen were shouting instructions like, "Build more here!" or "Stop, we have enough!" When the foremen were gone, the architects got confused. They stopped multiplying as fast as they should have.
• The Reality: The study found that the cells responsible for building the face were proliferating (growing) much slower. This led to smaller, underdeveloped features.

The Specific "Construction Defects"

Because the foremen were missing, the mice were born with several specific problems:

• Domed Skulls: Their heads looked like domes (like a helmet) instead of flat. This wasn't because the brain was too big, but because the skull bones didn't fuse or shape correctly.
• Missing Ear Bones: The tiny bones in the middle ear (the incus) were completely missing in some mice.
• Jaw Issues: The lower jaw (mandible) was shorter and smaller, especially in female mice.
• Palate Problems: The roof of the mouth had gaps or was misshapen, though not always a full "cleft palate."

The Twist: Boys vs. Girls and Strain Differences

The study also found that the "construction site" reacted differently depending on who was building it:

• Sex Differences: Male mice had bigger problems with their ears, while female mice had bigger problems with their jaws. It seems the "foremen" talk differently to male and female construction crews.
• Strain Differences: Mice from one genetic family (CD1) had much worse defects than mice from another family (C57BL/6). This is like saying one construction crew is more resilient to bad management than another.

The "Why": The Secret Language

Why did this happen? The researchers found that the missing foremen stopped sending out chemical letters (cytokines and chemokines).

• The Analogy: The foremen were supposed to be sending text messages to the architects saying, "Keep building!" or "We need more bricks here." When the foremen vanished, the text messages stopped. The architects (Neural Crest cells) didn't know what to do, so they slowed down or stopped working.

The Bottom Line

This paper teaches us that building a face isn't just about the cells that make the bone and skin. You also need the immune system cells (macrophages and osteoclasts) to act as the managers. They don't just clean up; they talk to the builders, tell them when to grow, and ensure the final structure is the right shape.

If you take away the managers, even if the builders are there, the house won't get built right. This helps explain why some people with genetic mutations affecting these immune cells have severe facial and bone deformities.

Technical Summary

1. Problem Statement

While the mechanisms of craniofacial morphogenesis are well-studied, the specific roles of fetal macrophages and osteoclasts during embryogenesis remain poorly characterized. Colony Stimulating Factor-1 Receptor (CSF1R) is essential for the survival and differentiation of mononuclear phagocytes (macrophages, microglia) and osteoclasts. Previous genetic models (e.g., Csf1 or Csf1r knockouts) and pharmacological studies have shown severe phenotypes like osteopetrosis and domed skulls, but they often lack temporal control or fail to fully characterize soft tissue development and the underlying cellular mechanisms (e.g., signaling to neural crest cells) during the embryonic period. This study aims to define the spatiotemporal impact of CSF1R+ cell depletion on craniofacial development, specifically investigating nerve, muscle, cartilage, and bone formation, and identifying the molecular drivers of observed defects.

2. Methodology

The study employed a pharmacological inhibition model using PLX5622, a potent CSF1R inhibitor, administered via chow to pregnant dams starting at embryonic day 3.5 (E3.5) to avoid disrupting implantation.

• Animal Models: The study utilized two mouse strains (CD1 and C57BL/6) and both sexes. Transgenic lines included Csf1rEGFP (to visualize CSF1R+ cells), Wnt1Cre;Rosa26tdTomato (to label Neural Crest Cells - NCCs), and standard wild-type strains.
• Cell Depletion Verification: Flow cytometry and immunofluorescence (IF) were used to quantify CSF1R+ cells (EGFP+ and antibody-stained) across gestation (E11.5–E17.5).
• Phenotypic Analysis:
  • Histology & Staining: Alcian blue (cartilage), von Kossa (bone mineralization), TRAP (osteoclast activity), Sp7 (osteoblasts), and immunostaining for apoptosis (Caspase-3), nerves (Neurofilament 2H3), and muscles (Myosin Heavy Chain MF20).
  • Morphometrics: Geometric morphometrics and manual measurements of skulls, mandibles, ear ossicles, and cranial bases at Postnatal day 1 (P1).
  • Micro-CT (µCT): High-resolution scanning to assess bone density, suture patency, and brain morphology (ventriculomegaly).
• Molecular & Cellular Mechanisms:
  • Cytokine Profiling: Luminex multiplex assay on E13.5 craniofacial tissue cultures to measure secreted cytokines/chemokines.
  • Single-Cell RNA Sequencing (scRNA-seq): Analysis of public datasets to map cytokine expression to specific CSF1R+ cell clusters.
  • Neural Crest Assays: In vitro sphere assays to test NCC proliferation capacity and in vivo quantification of NCC proliferation (Ki67) in E15.5 tissues.
  • Phagocytosis Assay: Testing if altered cytokine levels affect macrophage phagocytic function.

3. Key Contributions

• Temporal Resolution: Provided the first comprehensive characterization of craniofacial defects arising from CSF1R+ cell depletion specifically during the embryonic period (E15.5 to birth), distinguishing them from postnatal phenotypes.
• Sex and Strain Specificity: Demonstrated that PLX5622-induced phenotypes are highly dependent on genetic background (CD1 vs. C57BL/6) and sex, with females showing more severe mandibular defects and males showing more severe ear ossicle defects.
• Mechanistic Insight: Identified that the primary driver of craniofacial malformation is not just the loss of bone resorption (osteoclasts) but a reduction in Neural Crest Cell (NCC) proliferation caused by altered cytokine/chemokine signaling from depleted macrophages.
• Soft Tissue Characterization: Confirmed that while bone and cartilage are severely affected, gross nerve and muscle morphology remain largely intact during embryogenesis, suggesting secondary effects from bone deformation rather than primary developmental failure of soft tissues.

4. Key Results

A. Cell Depletion and Apoptosis:

• PLX5622 exposure resulted in a sustained ~50% depletion of CSF1R+ macrophages and a complete loss of osteoclasts (CTSK+/multinucleated) across gestation.
• Depletion was more rapid and consistent in males than females.
• Apoptosis (Caspase-3+) significantly increased in nervous (trigeminal, eye) and muscular (tongue) structures, but not in developing cartilage/bone (except the ear), suggesting macrophages are required for clearing apoptotic debris in soft tissues.

B. Craniofacial Morphogenesis Defects:

• Bone: E15.5 embryos showed increased bone density in the premaxilla and mandible (reduced unmineralized areas) despite the absence of osteoclasts, suggesting a disruption in the coupling of formation and resorption.
• P1 Phenotypes:
  • Skull: Severe doming of the cranial vault and impaired sagittal/coronal sutures.
  • Mandible: Significant shortening and reduced height, particularly in CD1 females.
  • Ear Ossicles: Absence of the incus, shortened malleus/stapes, and disrupted otic capsule mineralization.
  • Palate: Disrupted palatine processes and premaxilla thickness (resembling cleft palate but without full clefting).
  • Cranial Base: Widened synchondroses and shorter presphenoid bones.
• Strain Differences: CD1 mice exhibited severe phenotypes, while C57BL/6 mice showed milder, yet significant, defects (e.g., no skull length reduction in C57BL/6).
• Brain: µCT revealed ventriculomegaly (enlarged lateral/third ventricles) and cavitary lesions, suggesting mild hydrocephalus or structural brain changes contributing to skull doming.

C. Molecular Mechanisms:

• Cytokine Dysregulation: PLX5622 exposure caused significant downregulation of pro-inflammatory and osteogenic chemokines (CCL2, CCL3, CCL4, CCL12, CXCL1, CXCL10, IL-6, TNFα) and upregulation of CX3CL1 in craniofacial tissues.
• Source Validation: scRNA-seq and in situ hybridization confirmed that these cytokines are expressed by CSF1R+ macrophages and osteoclasts.
• Neural Crest Impact:
  • In vitro sphere assays showed a significant reduction in the number of primary neural crest-derived spheres from PLX5622-exposed embryos.
  • In vivo analysis at E15.5 revealed a significant decrease in tdTomato+ (NCC) cell numbers and Ki67+ (proliferating) cells in the premaxilla and mandible of treated embryos.
  • This suggests that the loss of macrophage-derived signals (e.g., CCL2, IL-6) directly impairs NCC proliferation, leading to insufficient progenitor pools for bone formation.

D. Exclusion of Other Causes:

• Skull doming was not caused by craniosynostosis (sutures were open but impaired) or midface hypoplasia alone.
• Nerve and muscle development (E11.5–E15.5) appeared grossly normal, indicating the bone defects are primary, and soft tissue issues are likely secondary to skeletal deformation.

5. Significance

• Developmental Biology: Establishes CSF1R+ macrophages and osteoclasts as critical regulators of neural crest cell proliferation during embryogenesis, linking immune cell signaling to skeletal morphogenesis.
• Human Disease Modeling: The phenotypes (skull doming, cranial base sclerosis, brain lesions, osteosclerosis) closely mimic BANDDOS (Brain Abnormalities, Neurodegeneration, and Dysosteosclerosis), a rare human disorder caused by bi-allelic CSF1R mutations. This model provides a tool to study the embryonic origins of these defects.
• Therapeutic Implications: Highlights the risks of CSF1R inhibitors (used in cancer and inflammatory diseases) on fetal development if administered during pregnancy, emphasizing the need for strict teratogenicity screening.
• Sexual Dimorphism: Underscores the importance of studying both sexes in craniofacial research, as the severity and nature of defects vary significantly between males and females.

In conclusion, the paper demonstrates that CSF1R+ cells are not merely passive bone resorbers but active signaling hubs that secrete cytokines essential for maintaining neural crest proliferation and proper craniofacial morphogenesis. Their depletion leads to a cascade of defects involving reduced progenitor pools, altered bone mineralization, and secondary brain structural changes.